BRPI0513807A - sìntese de amidas do ácido 6, 7 - diidro - 5h - imidazo [1, 2-a] imidazol - 3 - sulfÈnico - Google Patents

sìntese de amidas do ácido 6, 7 - diidro - 5h - imidazo [1, 2-a] imidazol - 3 - sulfÈnico

Info

Publication number
BRPI0513807A
BRPI0513807A BRPI0513807-8A BRPI0513807A BRPI0513807A BR PI0513807 A BRPI0513807 A BR PI0513807A BR PI0513807 A BRPI0513807 A BR PI0513807A BR PI0513807 A BRPI0513807 A BR PI0513807A
Authority
BR
Brazil
Prior art keywords
imidazo
dihydro
imidazole
sulfonic acid
acid amide
Prior art date
Application number
BRPI0513807-8A
Other languages
English (en)
Inventor
Xiao-Jun Wang
Thomas Wirth
Thomas Nicola
Li Zhang
Rogelio Perez Frutos
Yibo Xu
Dhileepkumar Krishnamurthy
Laurence John Nummy
Richard J Varsolona
Jutta Kroeber
Chris Hugh Senanayake
Original Assignee
Boehringer Ingelheim Pharma
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma, Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Pharma
Publication of BRPI0513807A publication Critical patent/BRPI0513807A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C275/24—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SìNTESE DE AMIDAS DO áCIDO 6,7 - DIIDRO - 5H - IMIDAZO ¢1,2-a! IMIDAZOL -3- SULFÈNICO. A presente invenção refere-se a um processo de múltiplas etapas para preparação de um composto da fórmula I, no qual de R¬ 1¬ a R¬ 3¬ são tal como definidos aqui. Os compostos da fórmula I inibem a ligação de moléculas de adesão intercelular humanas com as leucointegrinas. Por conseguinte, esses compostos são úteis no tratamento de doenças inflamatórias e imunológicas mediadas por células.
BRPI0513807-8A 2004-07-27 2005-07-25 sìntese de amidas do ácido 6, 7 - diidro - 5h - imidazo [1, 2-a] imidazol - 3 - sulfÈnico BRPI0513807A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59139804P 2004-07-27 2004-07-27
PCT/US2005/026148 WO2006014828A1 (en) 2004-07-27 2005-07-25 Synthesis of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid amides

Publications (1)

Publication Number Publication Date
BRPI0513807A true BRPI0513807A (pt) 2008-05-13

Family

ID=35429194

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0513807-8A BRPI0513807A (pt) 2004-07-27 2005-07-25 sìntese de amidas do ácido 6, 7 - diidro - 5h - imidazo [1, 2-a] imidazol - 3 - sulfÈnico

Country Status (12)

Country Link
US (2) US7470795B2 (pt)
EP (1) EP1776367A1 (pt)
JP (1) JP2008506786A (pt)
KR (1) KR20070047798A (pt)
CN (1) CN101027304A (pt)
AU (1) AU2005269634A1 (pt)
BR (1) BRPI0513807A (pt)
CA (1) CA2573398A1 (pt)
IL (1) IL180942A0 (pt)
MX (1) MX2007000907A (pt)
RU (1) RU2007106927A (pt)
WO (1) WO2006014828A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2573398A1 (en) * 2004-07-27 2006-02-09 Boehringer Ingelheim International Gmbh Synthesis of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid amides
KR20080025067A (ko) * 2005-05-19 2008-03-19 베링거 인겔하임 인터내셔날 게엠베하 6,7-디하이드로-5Ｈ-이미다조[1,2-ａ]이미다졸-3-설폰산의유도체
US20070173517A1 (en) * 2006-01-20 2007-07-26 Thomas Wirth Synthesis of 6,7-Dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonic acid amides
NZ585640A (en) * 2007-11-29 2011-03-31 Boehringer Ingelhelheim Internat Gmbh Derivatives of 6,7-dihydro-5h-imidazo[1,2-alpha]imidazole-3- carboxylic acid amides
PL2445909T3 (pl) 2009-06-02 2014-04-30 Boehringer Ingelheim Int Pochodne amidów kwasu 6,7-dihydro-5H-imidazo[1,2-a]imidazolo-3-karboksylowego
EP2445914B1 (en) 2009-06-02 2015-07-22 Boehringer Ingelheim International GmbH DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60246374A (ja) * 1984-05-18 1985-12-06 Daicel Chem Ind Ltd ２−アミノイミダゾリン化合物の製造方法
PL336580A1 (en) * 1997-03-03 2000-07-03 Boehringer Ingelheim Pharma Fine-molecular compounds useful in treating inflammatory diseases
US6492408B1 (en) * 1999-07-21 2002-12-10 Boehringer Ingelheim Pharmaceuticals, Inc. Small molecules useful in the treatment of inflammatory disease
MXPA03000914A (es) * 2000-08-09 2003-10-06 Boehringer Ingelheim Pharma Sintesis de (r)-3-(4 -bromobencil) -1-(3, 5-diclorofenil) -5-yodo-3 -metil-1-h -imidazo[1, 2-a]imidazol -2-ona.
JP3877549B2 (ja) * 2001-06-21 2007-02-07 三洋電機株式会社 加熱調理器
US6852748B1 (en) * 2002-10-30 2005-02-08 Boehringer Ingelheim Pharmaceuticals, Inc. Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide
US6844360B2 (en) 2002-10-30 2005-01-18 Boehringer Ingelheim Pharmaceuticals, Inc. Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide
CA2573398A1 (en) 2004-07-27 2006-02-09 Boehringer Ingelheim International Gmbh Synthesis of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid amides

Also Published As

Publication number Publication date
EP1776367A1 (en) 2007-04-25
JP2008506786A (ja) 2008-03-06
US7470795B2 (en) 2008-12-30
US20060025447A1 (en) 2006-02-02
CN101027304A (zh) 2007-08-29
RU2007106927A (ru) 2008-09-10
CA2573398A1 (en) 2006-02-09
IL180942A0 (en) 2007-07-04
US20090088571A1 (en) 2009-04-02
AU2005269634A1 (en) 2006-02-09
KR20070047798A (ko) 2007-05-07
WO2006014828A1 (en) 2006-02-09
MX2007000907A (es) 2007-04-13

Similar Documents

Publication Publication Date Title
TW200716589A (en) Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]-oxepino [4,5-c] pyrrole
BRPI0513807A (pt) sìntese de amidas do ácido 6, 7 - diidro - 5h - imidazo [1, 2-a] imidazol - 3 - sulfÈnico
EP2546256A3 (en) Process for the synthesis of intermediates compounds useful for the preparation of E1 activity activating enzyme inhibitors
BRPI0511138A (pt) derivados de pirimidina para o tratamento de desenvolvimento celular anormal
BR0307721A (pt) Processo para preparação de derivados de indolinona
BRPI0407967A (pt) processo de uma etapa para a preparação de derivados anticonvulsivantes
BR112014007721A2 (pt) processos para preparar compostos úteis como inibidores de atr quinase
BRPI0510394A (pt) inibidores de 11-beta-hidroxiesteróide desidrogenase tipo 1
DE602005017027D1 (de) Verfahren zur enzymatischen herstellung von (s)-3-cyano-5-methylhexansäure
BRPI0606115A2 (pt) processos para a preparação de compostos éteres de pirazol [3,4-d] pirimidina
BR0215622A (pt) Inibidores da dpiv com base em glutaminila
BRPI0407282A (pt) Processo para preparação de inibidores de pirrolotriazina cinase
BRPI0514741A (pt) derivados de hexahidro-pirazino[1, 2-a]pirimidina-4, 7-diona substituìdos por aminoácidos
WO2008049758A3 (de) Dispersionsfarbstoffe, ihre herstellung und ihre verwendung
TW200633977A (en) Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
BRPI0517390A (pt) processo para a preparação de derivados de [1,4,5]-oxadiazepina
BRPI0516172A (pt) processo para a preparação de 4,5-diidro-pirazol[3,4-c]pirid-2-onas
BR0208534A (pt) Processo para preparação de 4,6-diaminopirimido[5,4-d]pirimidinas
BRPI0713381A2 (pt) composto, composição farmacêutica, e, método para o tratamento de uma doença
UY28754A1 (es) Proceso quimico
EA200701852A1 (ru) Производные аминокислот
AR051991A1 (es) Procedimiento para la preparacion de anilinas
TW200736259A (en) Synthesis of 6,7-dihydro-5H-imidazo[1,2-a] imidazole-3-sulfonic acid amides
BR0317249A (pt) Método de preparar compostos de aminocianopiridina tricìclica
WO2007057767A3 (en) Amino acid derivatives

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]